Adeyinka C Adejumo1,2, George Cholankeril3, Umair Iqbal4, Eric R Yoo5, Brian C Boursiquot3, Waldo C Concepcion6, Donghee Kim3, Aijaz Ahmed3. 1. Department of Medicine, North Shore Medical Center, 81 Highland Ave., Salem, MA, 01970, USA. acadejumo@partners.org. 2. Department of Medicine, Tufts University School of Medicine, Boston, MA, USA. acadejumo@partners.org. 3. Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA. 4. Department of Medicine, Geisinger Medical Center, Danville, PA, USA. 5. Department of Internal Medicine, Santa Clara Valley Medical Center, San Jose, CA, USA. 6. Department of Surgery, Abdominal Transplantation, Stanford University School of Medicine, Stanford, CA, USA.
Abstract
BACKGROUND/AIMS: Alcoholic hepatitis (AH) can lead to sudden and severe hepatic decompensation necessitating recurrent hospitalizations. We evaluated the trends, predictors, and healthcare cost burden of AH-related readmissions in the USA. METHODS: Utilizing the National Readmissions Database 2010-2014, we performed a retrospective longitudinal analysis to identify the index readmission with AH for up to 90 days after discharge. Annual trends of 30- and 90-day AH-related readmissions were calculated. Predictors of 30- and 90-day readmission were determined by multivariate logistic regression. Annual healthcare cost burden associated with AH-linked readmissions was estimated. RESULTS: Of the 21,572 (unweighted: 50,769) AH-related hospitalizations, 4917 (22.8%) and 7890 (36.6%) were readmitted in 30 and 90 day, respectively, with rates that were statistically unchanged from 2010 to 2014. Predictors of 30-day readmissions included female gender, hepatitis C virus infection, cirrhosis, ascites, acute kidney injury, urinary tract infection, history of bariatric surgery, chronic pancreatitis, and high medical comorbidity index. Acute pancreatitis and palliative care consultation were associated with a lower risk of 30-day readmission. Predictors of 90-day readmission were similar to risk factors for 30-day readmission. From 2010 to 2014, the annual cost (and total hospitalization days) burden increased in 2014 to $164 million (22,244 days) and $321 million (42,772 days) for 30- and 90-day AH-related readmissions, respectively. CONCLUSION: Despite relatively stable trends in AH-related readmission, the total LOS and cost has been rising. A target-directed approach with a focus on high-risk subpopulations may help understand the unique challenges associated with the rising cost of AH-related readmissions.
BACKGROUND/AIMS: Alcoholic hepatitis (AH) can lead to sudden and severe hepatic decompensation necessitating recurrent hospitalizations. We evaluated the trends, predictors, and healthcare cost burden of AH-related readmissions in the USA. METHODS: Utilizing the National Readmissions Database 2010-2014, we performed a retrospective longitudinal analysis to identify the index readmission with AH for up to 90 days after discharge. Annual trends of 30- and 90-day AH-related readmissions were calculated. Predictors of 30- and 90-day readmission were determined by multivariate logistic regression. Annual healthcare cost burden associated with AH-linked readmissions was estimated. RESULTS: Of the 21,572 (unweighted: 50,769) AH-related hospitalizations, 4917 (22.8%) and 7890 (36.6%) were readmitted in 30 and 90 day, respectively, with rates that were statistically unchanged from 2010 to 2014. Predictors of 30-day readmissions included female gender, hepatitis C virus infection, cirrhosis, ascites, acute kidney injury, urinary tract infection, history of bariatric surgery, chronic pancreatitis, and high medical comorbidity index. Acute pancreatitis and palliative care consultation were associated with a lower risk of 30-day readmission. Predictors of 90-day readmission were similar to risk factors for 30-day readmission. From 2010 to 2014, the annual cost (and total hospitalization days) burden increased in 2014 to $164 million (22,244 days) and $321 million (42,772 days) for 30- and 90-day AH-related readmissions, respectively. CONCLUSION: Despite relatively stable trends in AH-related readmission, the total LOS and cost has been rising. A target-directed approach with a focus on high-risk subpopulations may help understand the unique challenges associated with the rising cost of AH-related readmissions.
Entities:
Keywords:
Cost; Length of stay; Predictors; Rate; Trends
Authors: Andrea Pace; Andreas de Weerth; Marc Berna; Katharina Hillbricht; Michael Tsokos; Michael Bläker; Klaus Pueschel; Ansgar W Lohse Journal: Clin Gastroenterol Hepatol Date: 2009-06-26 Impact factor: 11.382
Authors: Jasmohan S Bajaj; K Rajender Reddy; Puneeta Tandon; Florence Wong; Patrick S Kamath; Guadalupe Garcia-Tsao; Benedict Maliakkal; Scott W Biggins; Paul J Thuluvath; Michael B Fallon; Ram M Subramanian; Hugo Vargas; Leroy R Thacker; Jacqueline G O'Leary Journal: Hepatology Date: 2016-02-19 Impact factor: 17.425
Authors: Philippe Mathurin; John O'Grady; Robert L Carithers; Martin Phillips; Alexandre Louvet; Charles L Mendenhall; Marie-José Ramond; Sylvie Naveau; Willis C Maddrey; Timothy R Morgan Journal: Gut Date: 2010-10-12 Impact factor: 23.059
Authors: Lindsay Yoder; Andrea Mladenovic; Francis Pike; Raj Vuppalanchi; Haleigh Hanson; Laura Corbito; Archita P Desai; Naga Chalasani; Eric S Orman Journal: Am J Med Date: 2021-10-14 Impact factor: 4.965
Authors: Ashwani K Singal; Andrea DiMartini; Lorenzo Leggio; Juan P Arab; Yong-Fang Kuo; Vijay H Shah Journal: Alcohol Alcohol Date: 2022-09-10 Impact factor: 3.913
Authors: David Uihwan Lee; Harrison Chou; Edwin Wang; Gregory Hongyuan Fan; John Han; Kevin Chang; Jean Kwon; Ki Jung Lee; Jeremy Blanchard; Nathalie Helen Urrunaga Journal: Expert Rev Gastroenterol Hepatol Date: 2022-06-19 Impact factor: 4.095